Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Broncus Holding's OCF Yield % or its related term are showing as below:
HKSE:02216'
s OCF Yield % Range Over the Past 10 Years
Min: -90.81 Med: -28.2 Max: -1.53
Current: -20.63
During the past 7 years, the highest OCF Yield % of Broncus Holding was -1.53%. The lowest was -90.81%. And the median was -28.20%.
HKSE:02216's OCF Yield % is ranked worse than 84.94% of 850
companies
in the Medical Devices & Instruments industry
Industry Median: 1.785
vs HKSE:02216: -20.63
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Broncus Holding OCF Yield % Related Terms
Broncus Holding OCF Yield % Historical Data
* Premium members only.
The historical data trend for Broncus Holding's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02216 vs ABT, SYK, MDT: OCF Yield % Comparison
For the Medical Devices subindustry, Broncus Holding's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Broncus Holding OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Broncus Holding's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Broncus Holding's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Broncus Holding (HKSE:02216) has a OCF Yield % of -20.63 as of Aug. 30, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Broncus Holding and its competitors. According to the industry distribution chart, Broncus Holding ranks #722 out of 850 companies in the Medical Devices & Instruments industry, placing it in the top 84.9%.
Is Broncus Holding's OCF Yield % too high?
Broncus Holding's current OCF Yield % is -20.63. Based on the distribution chart, Broncus Holding ranks #722 out of 850 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Broncus Holding has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Broncus Holding's OCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Broncus Holding ranks #722 out of 850 companies for OCF Yield %. This places Broncus Holding in the lower half of its industry. The industry median OCF Yield % is 1.79. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.79, based on 850 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Broncus Holding and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Broncus Holding's current OCF Yield % is -20.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Broncus Holding stock overvalued right now?
Based on GuruFocus' analysis, Broncus Holding (HKSE:02216) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.15, compared to a current price of HK$0.66 — trading 336.7% above its estimated fair value. The current OCF Yield % is -20.63. Broncus Holding's overall GF Score™ is 43/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Broncus Holding (HKSE:02216), the current OCF Yield % is -20.63 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Broncus Holding (HKSE:02216) Overvalued in 2026?
Based on GuruFocus' analysis, Broncus Holding stock appears to be overvalued.
The current stock price of HK$0.66 is trading 336.7% above its estimated GF Value™ of HK$0.15.
GuruFocus considers Broncus Holding to be Significantly Overvalued.
Key valuation signals for HKSE:02216:
OCF Yield %: -20.63
GF Value™: HK$0.15 vs. price of HK$0.66 (336.7% above fair value)
No single metric tells the full story. See the HKSE:02216 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Broncus Holding Corp is focused on provision of interventional treatment of Chronic Obstructive Pulmonary Disease and lung cancer. It engages in the field of Interventional Pulmonology, providing solutions for lung diseases in China and globally. Its products portfolio includes the InterVapor Thermal Vapor Treatment System the only implantable medical device to treat COPD; BroncAblate Radiofrequency Ablation System the transbronchial interventional treatment product for lung cancer; Targeted Lung Denervation Radiofrequency Ablation System the self-developed targeted radiofrequency ablation system in China to reduce the risk of acute exacerbation of COPD. Geographically, the company operates in Chinese Mainland; European Union; and Other Regions.
43GF Score
Get the complete analysis for HKSE:02216
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02216 has been successfully added to your 
